FI965214A - Fusidihappotablettien valmistus - Google Patents

Fusidihappotablettien valmistus Download PDF

Info

Publication number
FI965214A
FI965214A FI965214A FI965214A FI965214A FI 965214 A FI965214 A FI 965214A FI 965214 A FI965214 A FI 965214A FI 965214 A FI965214 A FI 965214A FI 965214 A FI965214 A FI 965214A
Authority
FI
Finland
Prior art keywords
preparation
acid tablets
fusic
fusic acid
tablets
Prior art date
Application number
FI965214A
Other languages
English (en)
Swedish (sv)
Other versions
FI117666B (fi
FI965214A0 (fi
Inventor
Erik Preben Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI965214A publication Critical patent/FI965214A/fi
Publication of FI965214A0 publication Critical patent/FI965214A0/fi
Application granted granted Critical
Publication of FI117666B publication Critical patent/FI117666B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI965214A 1994-07-26 1996-12-27 Fusidihappotablettien valmistus FI117666B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9415048A GB9415048D0 (en) 1994-07-26 1994-07-26 Tablet
GB9415048 1994-07-26
EP9502904 1995-07-21
PCT/EP1995/002904 WO1996003128A1 (en) 1994-07-26 1995-07-21 Preparation of fusidic acid tablets

Publications (3)

Publication Number Publication Date
FI965214A true FI965214A (fi) 1996-12-27
FI965214A0 FI965214A0 (fi) 1996-12-27
FI117666B FI117666B (fi) 2007-01-15

Family

ID=10758888

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965214A FI117666B (fi) 1994-07-26 1996-12-27 Fusidihappotablettien valmistus

Country Status (20)

Country Link
EP (1) EP0773783B1 (fi)
JP (1) JP3853358B2 (fi)
KR (1) KR100358614B1 (fi)
CN (1) CN1070703C (fi)
AT (1) ATE209496T1 (fi)
AU (1) AU681980B2 (fi)
CA (1) CA2193235C (fi)
CZ (1) CZ286197B6 (fi)
DE (1) DE69524226T2 (fi)
DK (1) DK0773783T3 (fi)
ES (1) ES2163521T3 (fi)
FI (1) FI117666B (fi)
GB (1) GB9415048D0 (fi)
HU (1) HU221483B (fi)
NZ (1) NZ290806A (fi)
PL (1) PL180935B1 (fi)
PT (1) PT773783E (fi)
RO (1) RO118633B1 (fi)
RU (1) RU2140272C1 (fi)
WO (1) WO1996003128A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008659A1 (en) * 1997-08-20 1999-02-25 Fuisz Technologies Ltd. Process for improving flow and compression of tableting compositions
RU2418806C2 (ru) 2005-10-31 2011-05-20 Лео Фарма А/С Получение кристаллического антибиотика
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
JP5249568B2 (ja) * 2007-12-06 2013-07-31 旭化成ケミカルズ株式会社 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法
DE102008051783A1 (de) * 2008-10-17 2010-04-22 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Valsartan enthaltende Tablette
EP2382968A1 (en) 2010-03-26 2011-11-02 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Particle size distribution of fusidic acid granules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7411402A (nl) * 1973-09-13 1975-03-17 Leo Pharm Prod Ltd Werkwijze voor het bereiden van een middel tegen arthritis.
EP0300073A1 (en) * 1987-07-22 1989-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Use of fusidic acid in the treatment of aids-related complex and full-blown aids

Also Published As

Publication number Publication date
DK0773783T3 (da) 2002-04-02
CZ22997A3 (en) 1997-04-16
DE69524226T2 (de) 2002-06-27
WO1996003128A1 (en) 1996-02-08
ATE209496T1 (de) 2001-12-15
EP0773783B1 (en) 2001-11-28
DE69524226D1 (de) 2002-01-10
CA2193235A1 (en) 1996-02-08
RU2140272C1 (ru) 1999-10-27
GB9415048D0 (en) 1994-09-14
CZ286197B6 (cs) 2000-02-16
KR100358614B1 (ko) 2003-01-10
KR970704447A (ko) 1997-09-06
PL318261A1 (en) 1997-05-26
PL180935B1 (pl) 2001-05-31
PT773783E (pt) 2002-04-29
HU221483B (en) 2002-10-28
CA2193235C (en) 2008-03-18
JPH10502937A (ja) 1998-03-17
AU3164495A (en) 1996-02-22
CN1070703C (zh) 2001-09-12
EP0773783A1 (en) 1997-05-21
HU9700217D0 (en) 1997-04-28
NZ290806A (en) 1998-01-26
JP3853358B2 (ja) 2006-12-06
CN1154066A (zh) 1997-07-09
HUT76836A (en) 1997-11-28
RO118633B1 (ro) 2003-08-29
ES2163521T3 (es) 2002-02-01
FI117666B (fi) 2007-01-15
AU681980B2 (en) 1997-09-11
FI965214A0 (fi) 1996-12-27

Similar Documents

Publication Publication Date Title
IL135130A0 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
ATE180668T1 (de) S(+)-ibuprofen enthaltende arzneimittel
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
ES2149990T3 (es) Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.
EP0237241A3 (en) Calcium supplement compressed tablets
FI965214A (fi) Fusidihappotablettien valmistus
IL123185A0 (en) Stable solid formulation of enalapril salt and process for preparation thereof
GB2295966B (en) Direct compression tablets
TR200102802T2 (tr) Tabletlerin direk kompresyonla üretiminde, yüksek L-karnitin-alkanoil L-karnitinli granülat
HUT59316A (en) Process for producing solid, orally administrable dosage forms comprising iphosphamide as active ingredient
DK0836472T3 (da) Terapeutiske brusesammensætninger
ECSP961662A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion
BR0101880A (pt) Uma nova composição farmacêutica

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117666

Country of ref document: FI

MA Patent expired